Edition:
United States

Ucb SA (UCB.BR)

UCB.BR on Brussels Stock Exchange

77.90EUR
22 Feb 2019
Change (% chg)

€-0.24 (-0.31%)
Prev Close
€78.14
Open
€78.04
Day's High
€78.28
Day's Low
€77.24
Volume
255,154
Avg. Vol
367,234
52-wk High
€81.48
52-wk Low
€60.08

Chart for

About

Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia,... (more)

Overall

Beta: 0.92
Market Cap(Mil.): €11,689.79
Shares Outstanding(Mil.): 194.51
Dividend: 1.15
Yield (%): 1.34

Financials

  UCB.BR Industry Sector
P/E (TTM): 17.05 30.48 33.70
EPS (TTM): 3.53 -- --
ROI: 8.89 14.95 14.45
ROE: 12.31 16.27 15.96

Earnings vs. Estimates